What happened
Samsung Pharmaceutical disclosed convertible bonds to raise US$4.42M, about 4.4% of its market value.
For context, this raise equals about 4.4% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$4.42M |
| vs. market value | 4.4% |
| Filed | 2026-09-02, Material event report (convertible bonds) |
| Source | DART rcept 20260902000227 → open original filing |
Source: DART. Information only, not investment advice.